Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | ANPEP | P15144 | 1/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2715954 | 1.00 | USP2 (0.54) | USP2ALDH1A1ANPEPKEAP1SMN1; SMN2 | |
| SCHEMBL358783 | 1.00 | USP2 (0.54) | USP2ALDH1A1ANPEPKEAP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2383770 | 0.98 | ALDH1A1 (0.55) | USP2ALDH1A1ANPEPKEAP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2187515 | 0.98 | ALDH1A1 (0.55) | USP2ALDH1A1ANPEPKEAP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2187508 | 0.98 | ALDH1A1 (0.55) | USP2ALDH1A1ANPEPKEAP1SMN1; SMN2 | |
| SCHEMBL9547004 | 0.83 | USP2 (0.47) | USP2ALDH1A1ANPEPKEAP1SMN1; SMN2 | |
| SCHEMBL6680924 | 0.82 | — | — | |
| SCHEMBL1043849 | 0.82 | PIK3CD (0.39) | ALDH1A1ANPEPKDM4EMEN1KMT2A | |
| SCHEMBL17828102 | 0.80 | USP2 (0.58) | USP2ALDH1A1ANPEPKEAP1SMN1; SMN2 | |
| SCHEMBL372508 | 0.80 | USP2 (0.58) | USP2ALDH1A1ANPEPKEAP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055619-A1 | WATERPROOF ADHESIVE COMPOSITIONS AND FLOORING SYSTEMS | DICKENS CARROLL BENFORD (US) | 2026-02-26 | — | — | US | claimed |
| CN-119799151-A | Polyurethane coating for road marking and preparation method thereof | 万华化学集团股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| US-20240279420-A1 | POLYOL BLENDED LIQUID COMPOSITION FOR PRODUCTION OF HYDROCHLOROFLUOROOLEFIN BLOWN POLYURETHANE FOAM, AND ITS APPLICATION | TOSOH CORPORATION (JP) | 2024-08-22 | — | — | US | claimed |
| CN-117279971-A | Polyol complex liquid composition for producing hydrochlorofluoroolefin foam polyurethane foam and use thereof | 东曹株式会社 | 2023-12-22 | — | — | CN | claimed |
| US-20230212445-A1 | WATERPROOF ADHESIVE COMPOSITIONS | DICKENS CARROLL BENFORD (US) | 2023-07-06 | — | — | US | claimed |
| CN-107001744-B | Low molecular weight graft polymers for scale inhibitors | 赫尔克里士有限公司 | 2023-06-16 | — | — | CN | claimed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | claimed |
| EP-4114566-A1 | CATALYST COMPOSITION FOR POLYURETHANES | Momentive Performance Materials Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| WO-2022239734-A1 | POLYOL-BASED MIXED LIQUID COMPOSITION FOR PRODUCING HYDROCHLOROFUROOLEFIN FOAMED POLYURETHANE FOAM, AND USE THEREOF | 東ソー株式会社 | 2022-11-17 | — | — | WO | claimed |
| CN-115243789-A | Catalyst composition for polyurethane | 迈图高新材料公司 | 2022-10-25 | — | — | CN | claimed |
| EP-1183260-B1 | TRIPHENDIOXAZINE COMPOUNDS | CLARIANT FINANCE BVI LTD (VG) | 2005-09-28 | — | — | EP | claimed |
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. | 2005-01-27 | — | — | US | claimed |
| WO-2004098589-A1 | 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARMACEUTICALS, INC. (US) | 2004-11-18 | — | — | WO | claimed |
| JP-2003500408-A | — | — | 2003-01-07 | — | — | JP | claimed |
| EP-1183260-A1 | TRIPHENDIOXAZINE COMPOUNDS | Clariant Finance (BVI) Limited (VG) | 2002-03-06 | — | — | EP | claimed |
| US-6302923-B1 | PRINTING OR DYEING TEXTILES WITH TRIAZINE DYES,TRIPHENODIOXAZINE DYES, INK JET INKS FOR PAPER | CLARIANT FINANCE (BVI) LIMITED (VG) | 2001-10-16 | — | — | US | claimed |
| WO-2000071545-A1 | TRIPHENDIOXAZINE COMPOUNDS | CLARIANT FINANCE (BVI) LIMITED (VG) | 2000-11-30 | — | — | WO | claimed |
| EP-0220892-A2 | Cold flow improving fuel additive compound and fuel composition containing same | MOBIL OIL CORPORATION (US) | 1987-05-06 | — | — | EP | claimed |
| US-4657562-A | REACTION PRODUCT OF BRANCHED MONOACID AMIDE, EPOXIDE AND BRANCHED ACID | MOBIL OIL CORPORATION (US) | 1987-04-14 | — | — | US | claimed |
| US-4161475-A | OIL ADDITIVES, DISPERSANTS | THE LUBRIZOL CORPORATION (US) | 1979-07-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | BDKRB1, BDKRB2, BRS3 | USP2 4620/4885ALDH1A1 3054/4885ANPEP 1371/4885 |
| US-20260055619-A1 | WATERPROOF ADHESIVE COMPOSITIONS AND FLOORING SYSTEMS | TLN1, L1CAM, CDH1 | USP2 1822/4885ALDH1A1 3130/4885ANPEP 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.